199 related articles for article (PubMed ID: 25993153)
21. The case of synchronous occurrence of primary adenocarcinoma and squamous cell carcinoma in the same lobe of the lung.
Bacalja J; Tomasović Lončarić Č; Kukulj S; Nikolić I
Acta Clin Belg; 2017 Aug; 72(4):289-292. PubMed ID: 27667399
[TBL] [Abstract][Full Text] [Related]
22. Management of Small Cell Lung Cancer: Progress and Updates.
Altan M; Chiang AC
Cancer J; 2015; 21(5):425-33. PubMed ID: 26389768
[TBL] [Abstract][Full Text] [Related]
23. Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications.
Piacentini F; Rossi G; Casali C; Cadioli A; Barbieri E; Guarneri V
Lung Cancer; 2011 Oct; 74(1):145-8. PubMed ID: 21767893
[TBL] [Abstract][Full Text] [Related]
24. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
[TBL] [Abstract][Full Text] [Related]
25. Abandoning the Notion of Non-Small Cell Lung Cancer.
Relli V; Trerotola M; Guerra E; Alberti S
Trends Mol Med; 2019 Jul; 25(7):585-594. PubMed ID: 31155338
[TBL] [Abstract][Full Text] [Related]
26. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
[TBL] [Abstract][Full Text] [Related]
27. The molecular approach to diagnosis in lung cancer.
Moore DA; Le Quesne JP
Br J Hosp Med (Lond); 2015 May; 76(5):C74-6. PubMed ID: 25959953
[No Abstract] [Full Text] [Related]
28. [Recent Advances and Future Strategies for Small Cell Lung Cancer].
Shao W; Wang X; Liu D
Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):421-426. PubMed ID: 28641701
[TBL] [Abstract][Full Text] [Related]
29. [Grading of lung cancer].
Bohle RM; Schnabel PA
Pathologe; 2016 Jul; 37(4):314-9. PubMed ID: 27356985
[TBL] [Abstract][Full Text] [Related]
30. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
32. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Oser MG; Niederst MJ; Sequist LV; Engelman JA
Lancet Oncol; 2015 Apr; 16(4):e165-72. PubMed ID: 25846096
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma.
Hwang DH; Szeto DP; Perry AS; Bruce JL; Sholl LM
Arch Pathol Lab Med; 2014 May; 138(5):626-35. PubMed ID: 23738762
[TBL] [Abstract][Full Text] [Related]
34. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
[TBL] [Abstract][Full Text] [Related]
35. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
36. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic Features of Advanced Squamous NSCLC.
Socinski MA; Obasaju C; Gandara D; Hirsch FR; Bonomi P; Bunn P; Kim ES; Langer CJ; Natale RB; Novello S; Paz-Ares L; Pérol M; Reck M; Ramalingam SS; Reynolds CH; Spigel DR; Stinchcombe TE; Wakelee H; Mayo C; Thatcher N
J Thorac Oncol; 2016 Sep; 11(9):1411-22. PubMed ID: 27296106
[TBL] [Abstract][Full Text] [Related]
38. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
Kayser G
Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
[TBL] [Abstract][Full Text] [Related]
39. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.
Nardi-Agmon I; Abud-Hawa M; Liran O; Gai-Mor N; Ilouze M; Onn A; Bar J; Shlomi D; Haick H; Peled N
J Thorac Oncol; 2016 Jun; 11(6):827-37. PubMed ID: 26968885
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy for advanced non-small cell lung cancer with a focus on squamous cell carcinoma.
Kuribayashi K; Funaguchi N; Nakano T
J Cancer Res Ther; 2016; 12(2):528-34. PubMed ID: 27461605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
